Calidi Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLDI and other ETFs, options, and stocks.

About CLDI

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA. 

CEO
Eric E. Poma
CEOEric E. Poma
Employees
28
Employees28
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
28
Employees28

CLDI Key Statistics

Market cap
16.39M
Market cap16.39M
Price-Earnings ratio
-0.13
Price-Earnings ratio-0.13
Dividend yield
—
Dividend yield—
Average volume
187.64K
Average volume187.64K
High today
$0.5199
High today$0.5199
Low today
$0.4768
Low today$0.4768
Open price
$0.5001
Open price$0.5001
Volume
99.93K
Volume99.93K
52 Week high
$4.90
52 Week high$4.90
52 Week low
$0.35
52 Week low$0.35

People also own

Based on the portfolios of people who own CLDI. This list is generated using Robinhood data, and it’s not a recommendation.
BioVie
Reviva Pharmaceuticals
Aligos Therapeutics
Innoviz Technologies
Mobileye Global
Nexalin Technology
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.